Rawcliffe Adrian 4
4 · Wave Life Sciences Ltd. · Filed Dec 10, 2025
Insider Transaction Report
Form 4
Rawcliffe Adrian
Director
Transactions
- Exercise/Conversion
Ordinary Shares
2025-12-08$5.97/sh+42,000$250,740→ 54,700 total - Sale
Ordinary Shares
2025-12-08$15.00/sh−42,000$630,000→ 12,700 total - Exercise/Conversion
Share Option (right to buy)
2025-12-08−42,000→ 0 totalExercise: $5.97Exp: 2026-08-16→ Ordinary Shares (42,000 underlying)
Footnotes (2)
- [F1]The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2025.
- [F2]These share options are fully vested.